Centessa Pharmaceuticals plc Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Centessa Pharmaceuticals plc quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Centessa Pharmaceuticals plc Operating Income (Loss) for the quarter ending June 30, 2024 was -$44M, a 6.46% increase year-over-year.
  • Centessa Pharmaceuticals plc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$155M, a 16.7% increase year-over-year.
  • Centessa Pharmaceuticals plc annual Operating Income (Loss) for 2023 was -$171M, a 19.3% increase from 2022.
  • Centessa Pharmaceuticals plc annual Operating Income (Loss) for 2022 was -$212M, a 43.3% increase from 2021.
  • Centessa Pharmaceuticals plc annual Operating Income (Loss) for 2021 was -$374M, a 3483% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$171M +$41M +19.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$212M +$162M +43.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$374M -$364M -3483% Jan 30, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$10.4M -$5.39M -107% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 -$5.05M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.